Get started
Author

Anat Globerson Levin

Observed names: A Globerson-Levin, A. Globerson Levin, Anat Globerson, Anat Globerson-Levin, Anat Globerson-levin
ORCID: 0000-0001-7557-463X
Observed ORCID: 0000-0001-7557-463X
OpenAlex ID: A5072275404
CAR T cells: Building on the CD19 paradigm
2021 · Anat Globerson Levin, Isabelle Rivière, et al. · European Journal of Immunology · 67
PDF
Shaping Functional Avidity of CAR T Cells: Affinity, Avidity, and Antigen Density That Regulate Response
2021 · Raanan Greenman, Yoav Pizem, et al. · Molecular Cancer Therapeutics · 60
Extracellular Vesicles Derived from Chimeric Antigen Receptor-T Cells: A Potential Therapy for Cancer
2021 · Anat Aharon, Galit Horn, et al. · Human Gene Therapy · 55
Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
2014 · Anat Globerson-Levin, Tova Waks, et al. · Molecular Therapy · 50
PDF
Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin
2005 · Jeanne Shepshelovich, Lee Goldstein-Magal, et al. · Journal of Cell Science · 47
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
2021 · Liat Rousso-Noori, Ignacio Mastandrea, et al. · Nature Communications · 44
PDF
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity
2020 · Anat Globerson Levin, Moran Rawet Slobodkin, et al. · Cancer Immunology Research · 33
PDF
T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields
2021 · Gil Diamant, Hadar Simchony Goldman, et al. · The Journal of Immunology · 31
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer
2018 · Eva Zupančič, Caterina Curato, et al. · Nanomedicine Nanotechnology Biology and Medicine · 19
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer
2022 · Naamit Deshet-Unger, Galit Horn, et al. · Biomedicines · 17
PDF
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells
2021 · Yamit Shorer Arbel, Ben-Zion Katz, et al. · Frontiers in Oncology · 16
PDF
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach
2020 · Anat Globerson Levin, Natalie Kronik, et al. · Cancer Immunology Immunotherapy · 12
Volumetric Nanodroplet‐Enhanced Ultrasound Surgery Combined with Immune Checkpoint Inhibition as a Cancer Therapy Platform
2025 · Bar Glickstein, Mike Bismuth, et al. · Small · 11
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment
2016 · Maya Zigler, Alexei Shir, et al. · Cancer Immunology Research · 11
Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions
2023 · Julia Sajman, Oren Yakovian, et al. · Cells · 9
PDF
The Clinical Significance of Circulating Lymphocytes Morphology in Diffuse Large B-Cell Lymphoma As Determined by a Novel, Highly Sensitive Microscopy
2023 · Gil Fridberg, Galit Horn, et al. · Cancers · 5
PDF
Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapy
2025 · Wei-Hsin Liu, Anat Globerson Levin, et al. · Stem Cells Translational Medicine · 2
Intra-peritoneal CAR-T cell therapy shows promising results in a murine model of epithelial ovarian cancer (313)
2022 · Ido Laskov, Naamit Deshet-Unger, et al. · Gynecologic Oncology · 2
Allogeneic Veto-CAR CD8 T Cells Enabling Prolonged Graft Survival, Anti-Tumor Specificity, and Low Risk of Graft Versus Host Disease
2023 · Wei-Hsin Liu, Anat Globerson Levin, et al. · Blood · 1
P12.05 Evaluating the compatibility of tumor treating electric fields with key antitumoral immune functions
2019 · G Diamant, H Simchony, et al. · Neuro-Oncology · 1
Abstract LB329: Overcoming the blood-brain barrier to potentiate GD2-CAR T therapy using P-selectin-targeted nanomedicine
2026 · Giuseppe Longobardi, Adan Miari, et al. · Cancer Research
Review Article: The Evolution and Future of Immunotherapy: The Promise of CAR T Cell-Derived Extracellular Vesicles
2026 · Anat Aharon, Anat Globerson Levin · Critical Reviews™ in Oncogenesis
Volumetric Nanodroplet‐Enhanced Ultrasound Surgery Combined with Immune Checkpoint Inhibition as a Cancer Therapy Platform (Small 23/2025)
2025 · Bar Glickstein, Mike Bismuth, et al. · Small
PDF
Immunotherapy: IN-VIVO CAR: SPEEDING UP IMMUNOTHERAPY
2023 · S. Katan, G. Horn, et al. · Cytotherapy
Supplementary Materials and Methods and Supplementary Figure Legends from HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment
2023 · Maya Zigler, Alexei Shir, et al.
Works count: 34
Citation count: 493
H-index: 12
I10-index: 14
Year
Topic
Type